Converting the SF-12 into the EQ-5D: An Empirical Comparison of Methodologies

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.27, Iss.6, 2009-06, pp. : 491-505

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis

By Adams Roisin

PharmacoEconomics, Vol. 28, Iss. 6, 2010-06 ,pp. : 477-487

Adis International

Access to resources Recommend Favorite

EQ-5D advances in the UK and France

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 591, 2009-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Utilities of the EQ-5D: Transferable or Not?

By Knies Saskia

PharmacoEconomics, Vol. 27, Iss. 9, 2009-09 ,pp. : 767-779

Adis International

Access to resources Recommend Favorite

Does the EQ-5D Reflect Lost Earnings?

By Tilling Carl Krol Marieke Tsuchiya Aki Brazier John > Brouwer Werner

PharmacoEconomics, Vol. 30, Iss. 1, 2012-01 ,pp. : 47-61

Adis International

Access to resources Recommend Favorite

Health Utilities Using the EQ-5D in Studies of Cancer

By Pickard A. Simon Wilke Caitlyn T.

PharmacoEconomics, Vol. 25, Iss. 5, 2007-01 ,pp. : 365-384

Adis International

Access to resources Recommend Favorite